CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, today announced that management will present a company overview at the Piper Jaffray 21st Annual Health Care Conference on Wednesday, December 2, 2009, at 8:00 a.m. ET at The New York Palace Hotel.
